Search Results - "Trieschmann, Martha E."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience by Fernandez, Hubert H, Trieschmann, Martha E, Friedman, Joseph H

    Published in Clinical neuropharmacology (01-01-2004)
    “…Aripiprazole is the newest atypical antipsychotic (AA) drug to be released in the US. It is the only AA that is a partial agonist at the D2 and 5HT1a receptors…”
    Get full text
    Journal Article
  2. 2

    Long-term outcome of quetiapine use for psychosis among parkinsonian patients by Fernandez, Hubert H., Trieschmann, Martha E., Burke, Monica A., Jacques, Carol, Friedman, Joseph H.

    Published in Movement disorders (01-05-2003)
    “…To evaluate the long‐term efficacy and tolerability of quetiapine for psychosis among parkinsonian patients, a retrospective analysis of all parkinsonian…”
    Get full text
    Journal Article
  3. 3

    Quetiapine for psychosis in Parkinson's Disease versus dementia with Lewy bodies by FERNANDEZ, Hubert H, TRIESCHMANN, Martha E, BURKE, Monica A, FRIEDMAN, Joseph H

    Published in The journal of clinical psychiatry (01-06-2002)
    “…Most clinicians perceive psychosis in dementia with Lewy bodies (DLB) as more difficult to treat than Parkinson's disease, yet there are no reports comparing…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Rebound psychosis: Effect of discontinuation of antipsychotics in Parkinson's disease by Fernandez, Hubert H., Trieschmann, Martha E., Okun, Michael S.

    Published in Movement disorders (01-01-2005)
    “…To determine whether psychiatrically stable patients with a history of drug‐induced psychosis could be successfully weaned off their antipsychotic drug, we…”
    Get full text
    Journal Article
  6. 6

    Treatment of psychosis in Parkinson's disease: Safety considerations by FERNANDEZ, Hubert H, TRIESCHMANN, Martha E, FRIEDMAN, Joseph H

    Published in Drug safety (01-01-2003)
    “…Psychosis only rarely occurs in patients with untreated Parkinson's disease. Much more commonly, psychosis is induced by drug therapy for Parkinson's disease…”
    Get full text
    Journal Article
  7. 7

    Monozygotic twins discordant for Huntington disease after 7 years by Friedman, Joseph H, Trieschmann, Martha E, Myers, Richard H, Fernandez, Hubert H

    Published in Archives of neurology (Chicago) (01-06-2005)
    “…Huntington disease (HD) has only rarely been identified in identical twins. All described twins have had disease onset within 1 year of each other, suggesting…”
    Get more information
    Journal Article
  8. 8

    Botulinum toxin type B for gait freezing in Parkinson's disease by Fernandez, Hubert H, Lannon, Margaret C, Trieschmann, Martha E, Friedman, Joseph H

    Published in Medical science monitor (01-07-2004)
    “…Freezing of Gait (FOG) can be a serious problem in Parkinson's disease (PD) and is usually refractory to medical treatment. Botulinum toxin (BTX) type A has…”
    Get more information
    Journal Article
  9. 9

    New-Onset Diabetes Mellitus Among Parkinsonian Patients Treated with Long-term Quetiapine by Fernandez, Hubert H., McCown, Katie M., Romrell, Janet, Trieschmann, Martha E., Friedman, Joseph H., Jacobson, Charles E., Okun, Michael S.

    Published in Drug target insights (2008)
    “…Hubert H. Fernandez1, Katie M. McCown1, Janet Romrell1, Martha E. Trieschmann2, Joseph H. Friedman2, Charles E. Jacobson IV1 and Michael S. Okun1 1Dept. of…”
    Get full text
    Journal Article
  10. 10